The activity of
glucose-6-phosphate dehydrogenase (G6PD) appears to control a vascular smooth muscle relaxing mechanism regulated through cytosolic
NADPH oxidation. Since our recent studies suggest that
thiol oxidation-elicited dimerization of the 1α form of
protein kinase G (PKG1α) contributes to the relaxation of isolated endothelium-removed bovine pulmonary arteries (BPA) to
peroxide and responses to
hypoxia, we investigated whether cytosolic
NADPH oxidation promoted relaxation by PKG1α dimerization. Relaxation of BPA to G6PD inhibitors
6-aminonicotinamide (6-AN) and
epiandrosterone (studied under
hypoxia to minimize basal levels of
NADPH oxidation and PKG1α dimerization) was associated with increased PKG1α dimerization and PKG-mediated
vasodilator-stimulated phosphoprotein (VASP) phosphorylation. Depletion of PKG1α by small inhibitory
RNA (
siRNA) inhibited relaxation of BPA to 6-AN and attenuated the increase in VASP phosphorylation. Relaxation to 6-AN did not appear to be altered by depletion of
soluble guanylate cyclase (sGC). Depletion of G6PD,
thioredoxin-1 (Trx-1), and Trx reductase-1 (TrxR-1) in BPA with
siRNA increased PKG1α dimerization and VASP phosphorylation and inhibited force generation under aerobic and hypoxic conditions. Depletion of TrxR-1 with
siRNA inhibited the effects of 6-AN and enhanced similar responses to
peroxide. Peroxiredoxin-1 depletion by
siRNA inhibited PKG dimerization to
peroxide, but it did not alter PKG dimerization under
hypoxia or the stimulation of dimerization by 6-AN. Thus regulation of cytosolic
NADPH redox by G6PD appears to control PKG1α dimerization in BPA through its influence on Trx-1 redox regulation by the
NADPH dependence of TrxR-1.
NADPH regulation of PKG dimerization may contribute to vascular responses to
hypoxia that are associated with changes in
NADPH redox.